Get started
Author

Akemi Matsuo

Observed name: Matsuo, Akemi
ORCID: 0000-0002-8049-0366
Observed ORCID: 0000-0002-8049-0366
OpenAlex ID: A5038282033
A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection
2017 · Makoto Kosaka, Atsuhito Ushiki, et al. · Antimicrobial Agents and Chemotherapy · 32
PDF
Blood urea nitrogen-to-serum albumin ratio and A-DROP are useful in assessing the severity of Pneumocystis pneumonia in patients without human immunodeficiency virus infection
2020 · Jumpei Akahane, Atsuhito Ushiki, et al. · Journal of Infection and Chemotherapy · 31
PDF
Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib
2012 · Tomonobu Koizumi, Toshihiko Agatsuma, et al. · Clinical Lung Cancer · 29
PDF
EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study
2024 · Taisuke Araki, Shintaro Kanda, et al. · Respiratory Investigation · 12
C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study
2023 · Kei Sonehara, Ryota Ozawa, et al. · Thoracic Cancer · 12
PDF
Evaluation of the association between predictive factors and the development of immune‐related adverse events and prognostic factors for chemoimmunotherapy in patients with non‐small cell lung cancer: A multicenter retrospective study
2024 · Ryota Ozawa, Kei Sonehara, et al. · Cancer Medicine · 7
PDF
A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
2019 · Satoko Kako, Satoru Joshita, et al. · Case Reports in Oncological Medicine · 7
PDF
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
2023 · Taisuke Araki, Shintaro Kanda, et al. · Translational Lung Cancer Research · 6
PDF
Clinical analysis of EGFR‐positive non‐small cell lung cancer patients treated with first‐line afatinib: A Nagano Lung Cancer Research Group
2019 · Kei Sonehara, Takashi Kobayashi, et al. · Thoracic Cancer · 6
PDF
Predictive Factors Associated with Long-Term Response to Combination Immunotherapy in Patients with Untreated Advanced Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study
2023 · Kei Sonehara, Ryota Ozawa, et al. · Oncology · 5
The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019
2021 · Norihiko Goto, Yosuke Wada, et al. · Journal of Infection and Chemotherapy · 5
PDF
Vaginal delivery after improvement in COVID-19 by monoclonal antibody treatment: A case report and literature review
2022 · Eisuke Ogawa, Hirohisa Goto, et al. · Journal of Infection and Chemotherapy · 4
PDF
Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients with Advanced Non-Small Cell Lung Cancer Treated with a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective Study
2024 · Taro Hirabayashi, Kei Sonehara, et al. · Oncology · 3
PDF
Initial Therapeutic Approach with Pembrolizumab in Synchronous Multiple Cancers, Including Non-Small Cell Lung Cancer, Highly Positive for Programmed Death-Ligand 1 Expression
2022 · Tomonobu Koizumi, Shintaro Kanda, et al. · Chemotherapy · 2
Real‐World Data of Second‐Line Amrubicin Monotherapy in Patients With Extensive‐Stage Small Cell Lung Cancer Who Received First‐Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study
2026 · Kei Sonehara, Toshiharu Tsutsui, et al. · Cancer Medicine · 1
Real-world data after introduction of chemoimmunotherapy in patients with extensive-disease small cell lung cancer: A multicenter retrospective study
2025 · Taro Hirabayashi, Kei Sonehara, et al. · Respiratory Investigation · 1
EGFR mutation and ALK fusion-positive non-small cell lung cancer: a multicenter prospective cohort study in Nagano Prefecture, Japan
2023 · Takashi Kobayashi, Shintaro Kanda, et al. · Oncology in Clinical Practice · 1
PDF
Serial Cancer Development Three Times in a Patient with Fanconi Anemia
2021 · Katsuya Yanagisawa, Toshimichi Horiuchi, et al. · Case Reports in Oncology · 1
A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein‐Barr virus‐positive large B‐cell neoplasms
2019 · Shojiro Ichimata, Mikiko Kobayashi, et al. · Pathology International · 1
Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trials
2026 · Tatsuya Yazaki, Kei Sonehara, et al. · Current Problems in Cancer
A multicenter pilot study of afatinib re-challenge in patients with EGFR -mutated non-squamous non–small cell lung cancer previously treated with osimertinib.
2026 · Taisuke Araki, Ryo Ichikawa, et al. · Journal of Clinical Oncology
A-DROP and Blood Urea Nitrogen-to-Serum Albumin Ratio are Useful in Assessing the Severity of Pneumocystis Pneumonia in Patients Without Human Immunodeficiency Virus Infection: A Retrospective Study
2020 · Jumpei Akahane, Atsuhito Ushiki, et al. · Research Square
PDF
Results of sleep study conducted for one week in patients with end-stage renal disease undergoing maintenance hemodialysis
2019 · Akemi Matsuo, Atsushi Nakajima, et al. · European Respiratory Journal
Obstructive sleep apnea and metabolic syndrome in 1,600 adult Japanease PSG cases.
2018 · Akemi Matsuo, Kei Sonehara · European Respiratory Journal
Effects of CPAP on clinic blood pressure in patients with obstructive sleep apnea: 10 years follow –up
2017 · Akemi Matsuo, Kei Sonehara · European Respiratory Journal
Works count: 27
Citation count: 167
H-index: 7
I10-index: 5
Year
Topic
Type